JPMA Calls for Setting Broad Spillover Exclusions in Market Expansion Re-Pricing

JPMA Director General Kenshi Kinoshita The areas of exclusions from the so-called “spillover” market expansion re-pricing should be set as broadly as possible so as not to strife innovation, the Japan Pharmaceutical Manufacturers Association (JPMA) urged on January 18. “Since...read more